Mold, HLA and MTHFR: “You are not a victim of your genetics”

Genetic expression adapts—continuously—to internal and external environments. Epigenetic programs sense redox state, nutrient availability, inflammatory tone, and psychosocial stress and then tune gene activity accordingly. Genes load the gun; the terrain pulls (or removes) the trigger. (Nature)

Genetic “defects” as protective, not causative

HLA as adaptive immunogenetics

Human leukocyte antigen (HLA) diversity is shaped by pathogen-driven balancing selection: populations historically exposed to diverse microbes maintain a wide array of HLA variants because variation itself confers survival advantages. In this framework, many HLA alleles commonly labeled “susceptibility” are better understood as context-dependent protective strategies that optimize antigen presentation under specific environmental pressures. Their clinical expression depends on the current terrain (inflammation, oxidative stress, nutrient status), not destiny encoded in DNA. (ScienceDirect, PMC)

MTHFR as a context-dependent variant

C677T and A1298C MTHFR polymorphisms reduce enzyme activity and can raise homocysteine when methyl-nutrient status and redox balance are poor; yet their global distribution shows signals of environmental selection (e.g., UV-folate interactions), implying historical advantages in certain ecologies. In other words, these are adaptive variants whose net effects turn harmful chiefly when the terrain is unfavorable (low folate/B-vitamins, high oxidative stress, chronic inflammation). Professional guidelines also caution against overinterpreting MTHFR genotypes outside of clinical context. (Nature, PMC)

The common thread: iron dysregulation → oxidative stress → mitochondrial failure

Anemia of chronic inflammation (ACI) as the biochemical bridge

Under persistent immune activation, IL-6 induces hepcidin, which traps iron in storage, blocks iron export, and starves mitochondria of the iron needed for electron transport—while allowing iron to accumulate in tissues where it drives Fenton chemistry and reactive oxygen species. This two-sided lesion (energy deficit + oxidative injury) is the terrain that magnifies reactivity to environmental triggers. (PubMed)

Clinical expressions of this terrain:

• ME/CFS – energy failure and post-exertional crashes are consistent with impaired mitochondrial iron availability.

• Fibromyalgia – persistent oxidative stress sensitizes nociceptive pathways.

• Neurodegeneration – brain iron elevation and iron-dependent cell death (ferroptosis) are repeatedly linked to Alzheimer’s disease. (PubMed, PMC)

Why mold looks like “the bad guy” in a dysregulated system

Fungal fragments and mycotoxins are potent amplifiers of oxidative stress and immune activation. In a terrain already primed by ACI, mitochondrial under-fueling, and redox imbalance, exposures that a regulated person clears uneventfully can precipitate multisystem symptoms. The trigger (mold) is visible; the terrain (iron/redox/mitochondria) is the amplifier. (PubMed)

Psychophysiological stress compounds this: chronic allostatic load distorts neuroendocrine-immune crosstalk, raising inflammatory tone and oxidative stress—further lowering the threshold for reactivity to environmental inputs. (PMC)

CIRS playbooks (Shoemaker): serious concerns and iatrogenic risks

1) Genetic determinism and permanent-patient framing
Positioning HLA patterns as a lifelong sentence risks reinforcing fear and avoidance behaviors that perpetuate stress biology—counterproductive for redox and immune regulation. (See “Allostatic load,” above.) (PMC)

2) Bile-acid sequestrants (cholestyramine/colesevelam) without terrain rebuilding
These agents can bind not only bile acids but fat-soluble vitamins (A, D, E, K) and other nutrients; they may raise triglycerides and interfere with multiple drugs. Used chronically, they can deepen nutrient deficits and metabolic stress unless meticulously balanced with nutrition and monitoring. (NCBI, e-acnm.org)

3) Overinterpretation of biomarker surrogates and urine mycotoxin tests
Toxicology societies caution that common urine mycotoxin assays do not quantify inhalation exposure and have no established role in exposure assessment, making them poor stand-alone guides for treatment intensity. (ACMT)

4) NeuroQuant and disease specificity
Automated volumetric MRI tools (e.g., NeuroQuant®) are measurement aids. Volumes and z-scores depend on acquisition parameters, intracranial volume (ICV) adjustment, and the chosen normative database; different software can yield materially different values. These tools are not validated as disease-specific biomarkers for CIRS, and findings are confounded by age, head size, hydration, and comorbidities. Clinical meaning requires integration with broader physiology rather than algorithmic labeling. (Frontiers, KJR Online)

5) Hyper-avoidance as a physiological stressor
Exclusive emphasis on extreme environmental control can entrench sympathetic arousal and threat-monitoring, worsening oxidative stress and immune dysregulation—the very milieu that heightens environmental reactivity. (PMC)

MCAS, mast cells, and the redox connection

Mast cells are exquisitely sensitive to reactive oxygen species (ROS) and neuroimmune cues; oxidative stress potentiates degranulation and mediator release. This ties MCAS flares to the same terrain—iron-driven ROS and mitochondrial dysfunction—explaining why redox-rebalancing strategies often reduce symptom volatility even when exposures cannot be fully eliminated. (PubMed)

Reframing HLA and MTHFR: adaptive safety switches in a changing terrain

• HLA variants reflect long-term adaptation to pathogen landscapes; they modulate surveillance rather than dictating disease. Expression as chronic illness requires a permissive terrain (iron sequestration, oxidative stress, metabolic slowdown). (ScienceDirect, PMC)

• MTHFR variants alter methyl-flux and glutathione potential conditionally. Their geographic distributions and selection signals argue against inherent “defect” status; clinical impact hinges on folate/B-vitamin sufficiency, redox balance, and inflammation. Over-reliance on genotype (or routine testing) is discouraged by professional bodies. (Nature, PMC)

Practical implications: terrain-first strategy

1. Resolve iron misdistribution

   • Lower inflammatory drivers of hepcidin; re-establish physiologic iron recycling; avoid unnecessary iron loading when ferritin is high/TSAT low (functional deficiency). Expect improved mitochondrial throughput as bioavailable iron returns to enzymes. (PubMed)

2. Reduce oxidative stress at the source

   • Stabilize blood sugar and thyroid-driven thermogenesis; ensure sufficiency of antioxidant precursors (methionine cycle → glutathione) in ways consistent with MTHFR status and overall nutrition; correct mineral cofactors for redox enzymes. (Nature)

3. Support natural detoxification

   • Favor approaches that improve bile flow, mitochondrial ATP production, and glymphatic/lymphatic dynamics before (or alongside) any sequestrants; if bile-acid binders are used, co-manage ADEK vitamins, triglycerides, and drug timing interactions. (NCBI)

4. Recalibrate neuroimmune set-points

   • Reduce allostatic load (sleep, light, movement, breath-based vagal inputs); this lowers baseline inflammatory tone and raises the threshold for environmental reactivity. (PMC)

5. Environmental prudence without physiologic penalty

   • Clean, dry, well-ventilated spaces and sensible remediation are beneficial. The goal is resilience, not perpetual fear; avoidance should not substitute for terrain repair nor become a driver of sympathetic overactivation. (World Health Organization, NCBI)

Bottom line

“HLA susceptibility,” “MTHFR defects,” and “mold illness” are not deterministic labels. They are signals that the terrain—especially iron handling and redox balance—needs correction. When the terrain is restored, reactivity falls: the same exposures that once produced spiraling symptoms are processed and cleared by a more resilient system. In this light, common CIRS protocols that prioritize binders, genetic determinism, imaging surrogates, or extreme avoidance—without rebuilding metabolic and redox foundations—risk iatrogenic nutrient deficit, stress biology, and diagnostic overreach. A terrain-first, regulation-focused strategy better aligns with the biology of adaptation and with the evidence base on iron, oxidative stress, and neuroimmune function. (PubMed, NCBI, Frontiers, PMC, ACMT)

A More Complete Approach

Instead of seeing genetics as a lifelong sentence, we can view them as signals about how the body responds under stress. And instead of seeing mold as the ultimate enemy, we can recognize that mold reactivity is a symptom of imbalance.

A terrain-focused approach looks like this:

• Restoring iron regulation — Supporting ceruloplasmin activity, reducing hidden inflammation, and ensuring iron is safely bound and recycled.

• Reducing oxidative stress — Through metabolic support (blood sugar regulation, mineral balance, thyroid health) and restoring mitochondrial function.

• Calming the nervous system — Helping the body leave the chronic “danger response” so that immune signaling can normalize.

• Supporting detoxification naturally — When metabolism and iron are balanced, the body regains its innate ability to clear toxins — without reliance on aggressive binders.

This not only reduces mold sensitivity, but also addresses the same terrain imbalances that contribute to ME/CFS, fibromyalgia, and Alzheimer’s. Want to learn more? I discuss these issues extensively in my other blog articles, and you can schedule a free consultation to see how my approach might help you. Click here to go to my calendar and grab a time for us to help you connect the dots and map out a solution!

Selected references

Epigenetics and gene–environment: Jaenisch & Bird 2003. (Nature)
HLA balancing selection: Prugnolle 2005; Brandt 2018. (ScienceDirect, PMC)
Anemia of inflammation / hepcidin: Nemeth et al., JCI 2004. (PubMed)
Brain iron in Alzheimer’s: Nikseresht 2019; Mohammadi 2024. (PubMed, PMC)
Mycotoxins & oxidative stress: Marin 2013. (PubMed)
Allostatic load & immune dysregulation: Juszczyk 2021; Ravi 2021. (PMC)
Bile-acid sequestrants risks: StatPearls 2023 (cholestyramine; colesevelam); nutrient-drug interactions review. (NCBI, e-acnm.org)
ACMT 2025 mold position (urine mycotoxins). (ACMT)
Volumetry caveats (ICV adjustment; inter-software differences; “brain ruler”): Voevodskaya 2014; KJR 2021; Frontiers 2022. (Frontiers, KJR Online)
MTHFR–UV selection; clinical caution: Yafei 2012; ACMG 2013. (Nature)
Mast cells & ROS: Chelombitko 2016; Theoharides 2020. (PubMed)